Drugs / chlorproguanil

Trials 13 · a red edge is where a trial was stopped

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 11 trial
Phase 1 NCT00126971 Jul 2005 → ? Plasmodium falciparum malaria Centers for Disease Control and Prevention Terminated No outcome recorded
Phase 2/31 trial
Phase 2/3 NCT00158574 Jan 2005 → Apr 2008 malaria London School of Hygiene and Tropical Medicine Completed No outcome recorded
Phase 36 trials
Phase 3 NCT00393679 Jul 2007 → Dec 2009 malaria Institute of Tropical Medicine, Belgium Completed No outcome recorded
Phase 3 NCT00361114 Jul 2006 → Aug 2007 malaria London School of Hygiene and Tropical Medicine Terminated No outcome recorded
Phase 3 NCT00344006 Jun 2006 → Aug 2007 Plasmodium falciparum malaria GlaxoSmithKline Completed No outcome recorded
Phase 3 NCT00118794 Sep 2004 → Jun 2005 malaria London School of Hygiene and Tropical Medicine Completed No outcome recorded
Phase 3 NCT00158561 Feb 2004 → Mar 2006 Plasmodium vivax malaria London School of Hygiene and Tropical Medicine Completed No outcome recorded
Phase 3 NCT00146731 Jan 2004 → Sep 2007 malaria London School of Hygiene and Tropical Medicine Completed No outcome recorded
Phase 43 trials
Phase 4 NCT00119145 Jun 2005 → May 2006 malaria London School of Hygiene and Tropical Medicine Completed No outcome recorded
Phase 4 NCT00164710 Apr → Sep 2005 Plasmodium falciparum malaria Centers for Disease Control and Prevention Completed No outcome recorded
Phase 4 NCT00164359 Apr → Sep 2005 Plasmodium falciparum malaria Centers for Disease Control and Prevention Completed No outcome recorded
Phase not applicable2 trials
NCT00461578 Apr 2005 → Oct 2006 malaria London School of Hygiene and Tropical Medicine Completed No outcome recorded
NCT00111163 Mar 2004 → Mar 2006 anemia, malaria Centers for Disease Control and Prevention Completed No outcome recorded
Also used as a comparator or background therapy in 2 trials
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 21 trial
Phase 2 NCT00519467 Background Jun 2003 → Feb 2005 Plasmodium falciparum malaria GlaxoSmithKline Completed No outcome recorded
Phase 31 trial
Phase 3 NCT00371735 Background Apr 2006 → May 2007 Plasmodium falciparum malaria GlaxoSmithKline Completed No outcome recorded

Evidence & citations 9 cited values

Every value below carries the sentence it was read from. 17 sources stand behind the page.

FieldValueCited text
Known as Chlorproguanil “Artesunate+chlorproguanil-dapsone (AS+CD) was a potential alternative for treatment of uncomplicated malaria.” PMID 18575626 Jun 2008
14

NCT00393679

NCT00118794

NCT00361114

NCT00158574

NCT00519467

NCT00158561

NCT00164710

NCT00146731

NCT00461578

NCT00344006

NCT00126971

NCT00371735

NCT00111163

NCT00164359

Known as chlorproguanil HCl “The combination of chlorproguanil HCl (CPG) and dapsone (DDS) as chlorproguanil-dapsone has already been shown to be efficacious against P.falciparum in adults and children in...” NCT00371735
Known as CHLORPROGUANIL HYDROCHLORIDE ChEMBL registry synonym — accepted as the source's own label CHEMBL1213553
Known as Clorproguanil ChEMBL registry synonym — accepted as the source's own label CHEMBL1213553
Known as CPG “The combination of chlorproguanil HCl (CPG) and dapsone (DDS) as chlorproguanil-dapsone has already been shown to be efficacious against P.falciparum in adults and children in...” NCT00371735
1

“Chlorproguanil (CPG)-dapsone (DDS)-artesunate was in development for the treatment of uncomplicated Plasmodium falciparum malaria.” PMID 19517101 Jun 2009

Known as Lapudrine ChEMBL registry synonym — accepted as the source's own label CHEMBL1213553
Known as Proguanil hydrochloride related compound f ChEMBL registry synonym — accepted as the source's own label CHEMBL1213553
Known as Proguanil related compound f ChEMBL registry synonym — accepted as the source's own label CHEMBL1213553
Modality Small molecule CHEMBL1213553